Effects of tyroservatide on histone acetylation in lung carcinoma cells
Authors:
Open Access
- 23 November 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 128 (2) , 460-472
Abstract
Tyroservatide (YSV) is an active, low‐molecular weight polypeptide shown to have antitumor effects on experimental hepatocarcinoma and lung carcinoma. The focus of our study was to observe the effects of YSV on several human lung carcinoma cell lines and explore its antitumor mechanism via its effect on histone acetylation. Our results showed that YSV significantly inhibited the proliferation of human lung carcinoma A549, NCIH460, NCIH292 and NCIH1299 cells, induced G0/G1 cell cycle arrest and increased protein and mRNA levels of p21 and p27. Moreover, YSV treatment significantly inhibited histone deacetylase (HDAC) activity and resulted in the accumulation of acetylated histones H3 and H4 in total cellular chromatin and p21 gene‐associated chromatin regions. Together these data suggest that the antitumor effects of YSV might be mediated by its inhibition of HDAC activity, selectively upregulating the expression of p21 by increasing the acetylation of histones associated with p21 gene regions, resulting in an induction of G0/G1 cell cycle arrest and inhibition of the proliferation of tumor cells. Our findings demonstrate that YSV may exhibit potent therapeutical effects on lung carcinoma.Keywords
This publication has 30 references indexed in Scilit:
- Histone Deacetylase Inhibitors in Cancer TherapyCancer Investigation, 2006
- Tyroservatide Therapy for Tumor Growth, Invasion and Metastasis of Lewis Lung Carcinoma and Human Lung Carcinoma A549Oncology, 2006
- Gene‐chip analysis of the effect of tripeptide tyroservatide (YSV) on gene‐expression in human hepatocarcinoma BEL‐7402 tumors transplanted to nude miceMolecular Carcinogenesis, 2005
- Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2Journal of Biological Chemistry, 2005
- Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small‐cell lung cancer lines and drug‐resistant sublinesInternational Journal of Cancer, 2003
- Expression Profile of Histone Deacetylase 1 in Gastric Cancer TissuesJapanese Journal of Cancer Research, 2001
- Histone AcetyltransferasesAnnual Review of Biochemistry, 2001
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicatorsBioorganic & Medicinal Chemistry Letters, 1991